243 related articles for article (PubMed ID: 35797594)
1. Genetic Association Between Epigenetic Aging-Acceleration and the Progression of Mild Cognitive Impairment to Alzheimer's Disease.
Liu H; Lutz M; Luo S;
J Gerontol A Biol Sci Med Sci; 2022 Sep; 77(9):1734-1742. PubMed ID: 35797594
[TBL] [Abstract][Full Text] [Related]
2. Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
Li H; Liu H; Lutz MW; Luo S;
J Alzheimers Dis; 2023; 91(3):977-987. PubMed ID: 36530083
[TBL] [Abstract][Full Text] [Related]
3. Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
Liu H; Lutz M; Luo S;
J Alzheimers Dis; 2021; 84(3):1323-1335. PubMed ID: 34657885
[TBL] [Abstract][Full Text] [Related]
4. Association of Epigenetic Age Acceleration With Incident Mild Cognitive Impairment and Dementia Among Older Women.
Shadyab AH; McEvoy LK; Horvath S; Whitsel EA; Rapp SR; Espeland MA; Resnick SM; Manson JE; Chen JC; Chen BH; Li W; Hayden KM; Bao W; Kusters CDJ; LaCroix AZ
J Gerontol A Biol Sci Med Sci; 2022 Jun; 77(6):1239-1244. PubMed ID: 34417803
[TBL] [Abstract][Full Text] [Related]
5. Polygenic effects on the risk of Alzheimer's disease in the Japanese population.
Kikuchi M; Miyashita A; Hara N; Kasuga K; Saito Y; Murayama S; Kakita A; Akatsu H; Ozaki K; Niida S; Kuwano R; Iwatsubo T; Nakaya A; Ikeuchi T; ;
Alzheimers Res Ther; 2024 Feb; 16(1):45. PubMed ID: 38414085
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Aging Biomarkers Associated With Cognitive Impairment in Older African American Adults With Human Immunodeficiency Virus (HIV).
Shiau S; Arpadi SM; Shen Y; Cantos A; Ramon CV; Shah J; Jang G; Manly JJ; Brickman AM; Baccarelli AA; Yin MT
Clin Infect Dis; 2021 Dec; 73(11):1982-1991. PubMed ID: 34143869
[TBL] [Abstract][Full Text] [Related]
8. Joint Effect of ABCA7 rs4147929 and Body Mass Index on Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Shanghai Aging Study.
Xi J; Ding D; Zhao Q; Liang X; Zheng L; Guo Q; Hong Z; Fu H; Xu J; Xiao Q
Curr Alzheimer Res; 2020; 17(2):185-195. PubMed ID: 32183673
[TBL] [Abstract][Full Text] [Related]
9. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological Equivalence of the Clinical Diagnosis of Mild Cognitive Impairment in the National Alzheimer's Coordinating Center Uniform Data Set and Alzheimer's Disease Neuroimaging Initiative.
Kiselica AM; Benge JF;
Dement Geriatr Cogn Disord; 2021; 50(3):231-236. PubMed ID: 34186536
[TBL] [Abstract][Full Text] [Related]
11. Brain structure and allelic associations in Alzheimer's disease.
Moon SW; Zhao L; Matloff W; Hobel S; Berger R; Kwon D; Kim J; Toga AW; Dinov ID;
CNS Neurosci Ther; 2023 Apr; 29(4):1034-1048. PubMed ID: 36575854
[TBL] [Abstract][Full Text] [Related]
12. Accelerated epigenetic age and cognitive decline among urban-dwelling adults.
Beydoun MA; Shaked D; Tajuddin SM; Weiss J; Evans MK; Zonderman AB
Neurology; 2020 Feb; 94(6):e613-e625. PubMed ID: 31879275
[TBL] [Abstract][Full Text] [Related]
13. Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment.
Wang WY; Liu Y; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT;
Mol Neurobiol; 2017 Mar; 54(2):1111-1118. PubMed ID: 26803496
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
[TBL] [Abstract][Full Text] [Related]
15. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
[TBL] [Abstract][Full Text] [Related]
16. The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.
Guo LH; Alexopoulos P; Eisele T; Wagenpfeil S; Kurz A; Perneczky R
Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):325-33. PubMed ID: 22932720
[TBL] [Abstract][Full Text] [Related]
17. Degree of cognitive impairment does not signify early versus late mild cognitive impairment: confirmation based on Alzheimer's disease polygenic risk.
Elman JA; Vuoksimaa E; Franz CE; Kremen WS;
Neurobiol Aging; 2020 Oct; 94():149-153. PubMed ID: 32623261
[TBL] [Abstract][Full Text] [Related]
18. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of genetic difference between mild cognitive impairment and Alzheimer's disease through genome-wide association study].
Bai Z; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):342-346. PubMed ID: 29896728
[TBL] [Abstract][Full Text] [Related]
20. Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data.
Chandler J; Done N; Desai U; Georgieva M; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
J Prev Alzheimers Dis; 2024; 11(2):310-319. PubMed ID: 38374737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
